Cefuroxime Kern Pharma 250 mg film-coated tablets EFG

Spain
Brand name Cefuroxime Kern Pharma 250 mg film-coated tablets EFG
Form tablets, film-coated
Active substance / Dosage
CEFUROXIME AXETIL · 300,72 mg
Prescription type Prescription Only Medicine
Registration number 69957
Manufacturer Kern Pharma S.L.
Cefuroxime Kern Pharma 250 mg film-coated tablets EFG tablets, film-coated

Package leaflet: Information for the user

Introduction

Package leaflet: information for the user

Cefuroxime Kern Pharma 250 mg film-coated tablets EFG

Read all of this leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only, and you should not give it to others, even if they have the same symptoms as you, because it could harm them.
  • If you experience any adverse effects, consult your doctor, pharmacist, or nurse, even if they are adverse effects not listed in this leaflet. See section 4.

Contents of the leaflet:

  1. What Cefuroxime Kern Pharma is and what it is used for
  2. What you need to know before taking Cefuroxime Kern Pharma
  3. How to take Cefuroxime Kern Pharma
  4. Possible side effects
  5. How to store Cefuroxime Kern Pharma
  6. Contents of the pack and other information

1. What Cefuroxima Kern Pharma is and what it is used for

Cefuroxima Kern Pharma is an antibiotic used in both adults and children. It works by killing bacteria that cause infections. It belongs to a group of medicines called cephalosporins.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as flu or the common cold.

It is important that you follow your doctor's instructions regarding dosage, frequency, and duration of treatment.

Do not store or reuse this medicine. If you have any antibiotic left over after completing your treatment, return it to the pharmacy for proper disposal. Medicines must not be disposed of via wastewater or household waste.

Cefuroxima Kern Pharma is used to treat infections of:

  • throat
  • nasal sinuses
  • middle ear
  • lungs or chest
  • urinary tract
  • skin and soft tissues

Cefuroxima Kern Pharma may also be used to:

  • treat Lyme disease (an infection transmitted by ticks).

2. What you need to know before taking Cefuroxime Kern Pharma

Do not take Cefuroxime Kern Pharma:

  • If you are allergic (hypersensitive) to cephalosporins or to any of the other components of this medicine (listed in section 6).

  • If you have ever had a severe allergic reaction (hypersensitivity) to any other type of beta-lactam antibiotic (penicillins, monobactams, and carbapenems).

  • If you have ever developed severe skin rash or skin peeling, blisters, and/or mouth ulcers after treatment with cefuroxime or any other cephalosporin antibiotic.

  • If any of the above applies to you, do not take Cefuroxime Kern Pharma until you have consulted your doctor.

Take special care with Cefuroxime Kern Pharma

Severe skin reactions, including Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported with cefuroxime treatment. Seek immediate medical attention if you notice any symptoms related to these severe skin reactions described in section 4.

Warnings and precautions

Talk to your doctor or pharmacist before taking Cefuroxime Kern Pharma.

Cefuroxime is not recommended for children under 3 months of age, as safety and efficacy are unknown in this age group.

You should remain alert for certain symptoms such as allergic reactions, fungal infections (such as Candida), and severe diarrhea (pseudomembranous colitis) while taking Cefuroxime. This will help reduce the risk of possible complications. See “Symptoms to watch for” in section 4.

If you need blood tests

Cefuroxime Kern Pharma may affect blood test results for blood sugar levels or the Coombs test. If you need a blood test:

  • Inform the person performing the test that you are taking cefuroxime.

Taking Cefuroxime Kern Pharma with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines, including those obtained without a prescription.

Medicines used to reduce stomach acidity (e.g. antacids used to treat heartburn) may affect the action of Cefuroxime.

Probenecid

Oral anticoagulants

? Inform your doctor or pharmacist if you are taking any medicine of this type.

Oral contraceptives

Cefuroxime may reduce the effectiveness of oral contraceptives. If you are taking oral contraceptives while on Cefuroxime Kern Pharma, you should also use barrier contraceptive methods (such as, for example, condoms). Consult your doctor.

Pregnancy, breastfeeding, and fertility

Consult your doctor before taking Cefuroxime Kern Pharma:

  • If you are pregnant, think you might be pregnant, or plan to become pregnant
  • If you are breastfeeding.

Your doctor will assess the benefit of treatment with Cefuroxime against the potential risk to your baby.

Driving and using machines

Cefuroxime may cause dizziness and provoke other adverse effects that could impair your ability to remain alert.

? Do not drive or operate machinery if you do not feel well.

3. How to take Cefuroxime Kern Pharma

Follow exactly the instructions for use of this medicine provided by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

Take Cefuroxime Kern Pharma after meals. This will help make the treatment more effective.

Swallow the Cefuroxime Kern Pharma tablets whole with water.

Do not chew, crush, or split the tablets — this may make the treatment less effective.

Usual dose

Adults

The usual dose of Cefuroxime is 250 mg to 500 mg twice daily, depending on the severity and type of infection.

Children

The usual dose of Cefuroxime is 10 mg/kg of the child's body weight (up to a maximum of 125 mg) to 15 mg/kg of the child's body weight (up to a maximum of 250 mg) twice daily, depending on:

  • the severity and type of infection

Cefuroxime is not recommended in children under 3 months of age, as the safety and efficacy in this patient group are unknown.

Depending on the illness and how you or your child responds to treatment, the initial dose may be adjusted or more than one course of treatment may be required.

Patients with kidney problems

If you have kidney problems, your doctor may adjust your dose.

? Consult your doctor if you are affected by this condition.

If you take more Cefuroxime Kern Pharma than you should

If you take too much Cefuroxime Kern Pharma, you may experience neurological disturbances, particularly an increased risk of epileptic seizures (convulsions).

? Do not delay. Contact your doctor or the nearest hospital emergency department immediately. If possible, show them the Cefuroxime Kern Pharma packaging.

You may also call the Toxicology Information Service at telephone number 91 562 04 20, stating the name of the medicine and the amount ingested.

If you forget to take Cefuroxime Kern Pharma

Do not take a double dose to make up for forgotten doses. Simply continue with the next dose as usual.

Do not stop treatment with Cefuroxime Kern Pharma without prior advice.

It is important that you complete the full course of treatment with Cefuroxime Kern Pharma. Do not stop unless instructed by your doctor, even if you start to feel better. If you do not complete the full course, the infection may recur.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone will experience them.

Symptoms to watch for

A small number of people who took cefuroxime experienced an allergic reaction or a potentially serious skin reaction. Symptoms of these reactions include:

  • Widespread rash, high body temperature, and enlarged lymph nodes (DRESS syndrome or drug hypersensitivity syndrome)

  • Chest pain occurring in the context of allergic reactions, which may be a symptom of a heart attack triggered by allergy (Kounis syndrome)

  • Severe allergic reaction. Signs include skin rash with itching, swelling, sometimes of the face or mouth, causing difficulty breathing

  • Skin rash, which may cause blisters, appearing like small targets (a dark spot in the center surrounded by a lighter area, with a dark ring around the edge)

  • Widespread skin rash with blisters and peeling skin. (These may be symptoms of Stevens-Johnson syndrome or toxic epidermal necrolysis)

  • Fungal infections. Medicines such as Cefuroxime can cause increased growth of fungi (Candida) in the body, leading to fungal infections (such as thrush). This side effect is more likely if Cefuroxime has been taken for a prolonged period

  • Severe diarrhoea (pseudomembranous colitis). Medicines such as Cefuroxime can cause inflammation of the colon (large intestine), resulting in severe diarrhoea, usually accompanied by blood and mucus, stomach pain, and fever

  • Jarisch-Herxheimer reaction. Some patients may experience an increase in body temperature (fever), chills, headache, muscle pain, and skin rash while taking Cefuroxime Kern Pharma to treat Lyme disease. This is known as a Jarisch-Herxheimer reaction. Symptoms usually last from a few hours to one day.

  • Contact a doctor or nurse immediately if you experience any of these symptoms.

Common adverse effects

May affect up to 1 in 10 patients:

  • fungal infection (such as Candida)
  • headache
  • dizziness
  • diarrhoea
  • nausea
  • stomach pain

Common adverse effects that may appear in blood tests:

  • increased count of a type of white blood cells (eosinophilia)
  • increased levels of liver enzymes

Uncommon adverse effects

May affect up to 1 in 100 patients:

  • vomiting
  • skin rashes

Uncommon adverse effects that may appear in blood tests:

  • decrease in the number of blood platelets (cells that help blood to clot)
  • decrease in the number of white blood cells
  • positive Coombs test

Other adverse effects

Other adverse effects have been reported in a very small number of people, but their exact frequency is unknown:

  • severe diarrhoea (pseudomembranous colitis)
  • allergic reactions
  • skin rashes (which may be severe)
  • high fever
  • yellowing of the whites of the eyes or of the skin
  • inflammation of the liver (hepatitis)

Adverse effects that may appear in blood tests:

  • rapid destruction of red blood cells (haemolytic anaemia)

  • Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an effect not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines: www.notificaRAM.es.

By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Cefuroxime Kern Pharma

No special storage conditions are required.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Dispose of unused medicines and their containers at the SIGRE collection point at your pharmacy. If you have any doubts, ask your pharmacist how to properly dispose of unused medicines and their packaging. This will help protect the environment.

6. Contents of the pack and other information

Composition of Cefuroxime Kern Pharma

  • The active substance is cefuroxime. Each tablet contains 250 mg of cefuroxime (as cefuroxime axetil).
  • The other components (excipients) are: pregelatinized corn starch (corn starch), sodium croscarmellose (AC-Disol SD-711), sodium lauryl sulfate, microcrystalline cellulose, anhydrous colloidal silica, hydrogenated vegetable oil, Opadry.

Appearance of the medicine and contents of the pack

Light blue, film-coated, biconvex, capsule-shaped tablets.

Each box contains 10, 15 or 20 film-coated tablets.

Marketing Authorization Holder and Manufacturer

Kern Pharma, S.L.

Venus 72 - Pol. Ind. Colón II

08228 Terrassa – Barcelona

Spain

Date of the most recent revision of this leaflet: May 2023

Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es